<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04272515</url>
  </required_header>
  <id_info>
    <org_study_id>C19-36</org_study_id>
    <nct_id>NCT04272515</nct_id>
  </id_info>
  <brief_title>Molecular Characterization for Understanding Biliary Atresia</brief_title>
  <acronym>CAVB</acronym>
  <official_title>Molecular Characterization for Understanding Biliary Atresia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although considered a rare disease, Biliary Atresia (BA) is the leading cause of neonatal&#xD;
      cholestasis and liver transplantation in children. Little is known about the molecular&#xD;
      mechanisms that drive BA. The purpose of this study is to collect the fluid samples,&#xD;
      explanted liver tissue samples and dermal biopsy samples to enable investigators to perform&#xD;
      the genetic and molecular analyses that might point to the gene(s) and cellular pathway&#xD;
      involved in etiology of BA disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Biliary atresia (BA) is a disease characterized by intra- and extra-hepatic bile duct&#xD;
      obstruction diagnosed in the neonatal period. If left untreated, this obstruction leads to&#xD;
      biliary cirrhosis and early death. Although considered a rare disease (between 1/15,000 and&#xD;
      1/20000 births), it is the leading cause of neonatal cholestasis and liver transplantation in&#xD;
      children. The reasons for this obstruction are still poorly known and might involve several&#xD;
      factors (immune, infectious and possible toxin effect). The accumulating evidence point to&#xD;
      genetic factors involved, yet they are not of the classic monogenic or Mendelian types. The&#xD;
      purpose of this study is to collect the fluid samples, explanted liver tissue samples and&#xD;
      dermal biopsy samples to enable investigators to perform the genetic and molecular analyses&#xD;
      that might point to the gene(s) and cellular pathway involved in etiology of BA disease.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 7, 2021</start_date>
  <completion_date type="Anticipated">February 7, 2032</completion_date>
  <primary_completion_date type="Anticipated">February 7, 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>BA patients and their parents will be enrolled in this study.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To identify the molecular mechanisms implicated in the etiology of BA</measure>
    <time_frame>10 Years</time_frame>
    <description>To identify gene(s) and cellular pathways affected in cells and liver tissue of BA patients: sequencing experiments</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Biliary Atresia</condition>
  <arm_group>
    <arm_group_label>BA patients and their parents</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Collection of blood samples from BA patients and their parents&#xD;
Collection of explanted liver tissue and skin biopsy of BA patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood sampling</intervention_name>
    <description>collection of blood sample for preparation of DNA</description>
    <arm_group_label>BA patients and their parents</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>skin biopsy sampling</intervention_name>
    <description>preparation of primary cultures of dermal fibroblasts from skin biopsy sample</description>
    <arm_group_label>BA patients and their parents</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>explanted liver of BA patients sampling</intervention_name>
    <description>cryoconservation of liver tissue for molecular analyses</description>
    <arm_group_label>BA patients and their parents</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  confirmed diagnosis of biliary atresia in patients&#xD;
&#xD;
          -  parents of BA patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  no&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hopital Necker enfants malades</name>
      <address>
        <city>Paris</city>
        <state>De</state>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Muriel Girard, MD</last_name>
      <phone>01 44 49 44 12</phone>
      <email>muriel.girard@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>PRC Inserm</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ganna PANASYUK, Dr</last_name>
      <phone>0172606387</phone>
      <email>ganna.panasyuk@inserm.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>January 28, 2020</study_first_submitted>
  <study_first_submitted_qc>February 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2020</study_first_posted>
  <last_update_submitted>June 3, 2021</last_update_submitted>
  <last_update_submitted_qc>June 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Biliary Atresia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

